| 7th Dec 2022 7:00 am |
RNS |
Product launch in dCELL® division |
| 22nd Nov 2022 7:00 am |
RNS |
Distribution agreement - OrthoPure® XT in Germany |
| 14th Nov 2022 6:05 pm |
RNS |
Holding(s) in Company |
| 7th Nov 2022 2:35 pm |
RNS |
Holding(s) in Company |
| 29th Sep 2022 10:13 am |
RNS |
Director/PDMR Shareholding |
| 27th Sep 2022 7:15 am |
EQS |
Hardman & Co Research on Tissue Regenix (TRX): Operating leverage |
| 7th Sep 2022 7:00 am |
RNS |
Half-year Report |
| 22nd Aug 2022 3:31 pm |
RNS |
Holding(s) in Company |
| 18th Aug 2022 5:36 pm |
RNS |
Holding(s) in Company |
| 18th Aug 2022 2:10 pm |
RNS |
Holding(s) in Company |
| 11th Aug 2022 4:30 pm |
EQS |
Hardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct |
| 11th Aug 2022 12:46 pm |
RNS |
Holding(s) in Company |
| 11th Aug 2022 12:17 pm |
RNS |
Holding(s) in Company |
| 11th Aug 2022 7:00 am |
RNS |
Confirmation of Interim Results |
| 5th Aug 2022 3:19 pm |
RNS |
Holding(s) in Company |
| 1st Aug 2022 3:14 pm |
RNS |
Holding(s) in Company |
| 19th Jul 2022 2:30 pm |
EQS |
Hardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential |
| 19th Jul 2022 7:00 am |
RNS |
Half Year Trading Update and Notice of Results |
| 18th Jul 2022 2:42 pm |
RNS |
Holding(s) in Company |
| 18th Jul 2022 1:33 pm |
RNS |
Holding(s) in Company |
| 15th Jul 2022 5:29 pm |
RNS |
Holding(s) in Company |
| 27th Jun 2022 6:04 pm |
RNS |
Holding(s) in Company |
| 27th Jun 2022 12:58 pm |
RNS |
Holding(s) in Company |
| 16th Jun 2022 1:27 pm |
RNS |
Exercise of Options and Total Voting Rights |
| 28th Apr 2022 7:00 am |
RNS |
OrthoPure®XT clinical results presentation |
| 26th Apr 2022 4:19 pm |
RNS |
Result of AGM |
| 20th Apr 2022 4:26 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2022 7:15 am |
EQS |
Hardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability |
| 8th Apr 2022 7:00 am |
RNS |
Grant of share options |
| 6th Apr 2022 2:59 pm |
RNS |
Director/PDMR Shareholding |
| 15th Mar 2022 7:00 am |
RNS |
Final year results for the year ended 31 Dec 2021 |
| 9th Mar 2022 7:00 am |
RNS |
Distribution agreement for OrthoPure® XT |
| 2nd Mar 2022 7:00 am |
RNS |
Notice of Results |
| 10th Feb 2022 3:45 pm |
RNS |
Additional Director Disclosures |
| 27th Jan 2022 7:00 am |
RNS |
Full Year Trading update |
| 23rd Dec 2021 7:00 am |
RNS |
Director/PDMR Shareholding |
| 21st Dec 2021 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 21st Dec 2021 2:01 pm |
RNS |
Price Monitoring Extension |
| 19th Oct 2021 1:15 pm |
EQS |
Hardman & Co Research: Tissue Regenix (TRX): Faster-than-anticipated recovery |
| 8th Oct 2021 7:00 am |
RNS |
Holding(s) in Company |
